Adjuvant Hepatic Arterial Chemotherapy Following Metastasectomy in Patients with Isolated Liver Metastases

Keyphrases

• Isolated Liver Metastasis 100%
• Overall Survival Benefit 100%
• Metastasectomy 100%
• Hepatic Arterial Infusion Chemotherapy 100%
• Progression-free Survival 50%
• Overall Survival 50%
• Statistical Methods 50%
• Chemotherapy 50%
• Retrospective Review 50%
• Disease-free Survival 50%
• Recent Advances 50%
• Stent 50%
• Systemic Therapy 50%
• Gross Total Resection 50%
• Liver Failure 50%
• Potential Toxicity 50%
• Liver Resection 50%
• Institutional Experience 50%
• Potential Side Effects 50%
• Resectable Disease 50%
• Neoadjuvant Setting 50%
• Liver Metastasis 50%
• Hepatotoxicity 50%
• Non-hepatic 50%
• Floxuridine 50%
• Confirmatory Trials 50%
• Intrahepatic Recurrence 50%

Nursing and Health Professions

• Overall Survival 100%
• Liver Metastasis 100%
• Intraarterial Drug Administration 100%
• Metastasis Resection 100%
• Isolated Liver 100%
• Recurrent Disease 33%
• Progression Free Survival 33%
• Side Effect 33%
• Stent 33%
• Statistical Analysis 33%
• Liver Failure 33%
• Disease Free Survival 33%
• Liver Resection 33%
• Systemic Therapy 33%
• Liver Toxicity 33%
• Sclerosis 33%
• Floxuridine 33%
• Surgery 33%
• Diseases 33%

Medicine and Dentistry

• Overall Survival 100%
• Liver Metastasis 100%
• Metastasectomy 100%
• Intraarterial Drug Administration 100%
• Progression Free Survival 33%
• Statistical Analysis 33%
• Recurrent Disease 33%
• Systemic Therapy 33%
• Disease Free Survival 33%
• Side Effect 33%
• Liver Failure 33%
• Hepatectomy 33%
• Sclerosis 33%
• Liver Toxicity 33%
• Floxuridine 33%
• Surgery 33%
• Diseases 33%